Ipilimumab/NivolumabHepatotoxicity: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2038卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72277-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：168 / 168

相关论文

共 50 条

[21] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2023, 1954 (1) : 261 - 261
[22] Ipilimumab/nivolumabHyperthyroidism: case report
Reactions Weekly, 2022, 1916 (1) : 241 - 241
[23] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2021, 1847 (1) : 259 - 259
[24] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2022, 1920 (1) : 268 - 268
[25] Ipilimumab/sintilimabAsthma: case report
Reactions Weekly, 2022, 1890 (1) : 143 - 143
[26] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2022, 1887 (1) : 397 - 397
[27] Ipilimumab/nivolumabColitis: case report
Reactions Weekly, 2020, 1826 (1) : 185 - 185
[28] Ipilimumab/nivolumabColitis: case report
Reactions Weekly, 2023, 1942 (1) : 157 - 157
[29] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2019, 1748 (1) : 266 - 266
[30] Ipilimumab/pembrolizumabHypophysitis: case report
Reactions Weekly, 2022, 1909 (1) : 306 - 306

← 1 2 3 4 5 →